Trump DOJ Surprises by Defending FDA Approval of Abortion Pill

In a move that caught many off guard, the Trump Department of Justice filed a brief urging dismissal of a lawsuit by several red-state attorneys general seeking to revoke the FDA’s approval of mifepristone. DOJ lawyers argued the states lack standing and that the FDA retains broad authority over drug approvals. This stance aligns with Trump’s declared position not to ban abortion pills at the federal level but stands in contrast to his broader anti-abortion rhetoric. Observers note that while DOJ’s argument is largely procedural, it effectively shields medication abortion from immediate prohibition.